Cardioprotective Potential of Berries of Schisandra chinensis Turcz. (Baill.), Their Components and Food Products

被引:14
作者
Olas, Beata [1 ]
机构
[1] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Pomorska 141-3, PL-90236 Lodz, Poland
关键词
berry; lignans; phenolic compounds; safety; schisandrin; Schisandra chinensis; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION INJURY; ANTIOXIDANT; LIGNANS; POLYSACCHARIDE; HYPERTENSION; ENHANCEMENT; CAPACITY; PROTECTS; EXTRACT;
D O I
10.3390/nu15030592
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Schisandra chinensis (S. chinensis) berries, originally a component of traditional herbal medicine in China, Korea, and other east Asian countries, are also valuable agents in modern phototherapy. S. chinensis berry preparations, including extracts and their chemical components, demonstrate anti-cancer, hepatoprotective, anti-inflammatory, and antioxidant properties, among others. These valuable properties, and their therapeutic potential, are conditioned by the unique chemical composition of S. chinensis berries, particularly their lignan content. About 40 of these compounds, mainly dibenzocyclooctane type, were isolated from S. chinensis. The most important bioactive lignans are schisandrin (also denoted as schizandrin or schisandrol A), schisandrin B, schisantherin A, schisantherin B, schisanhenol, deoxyschisandrin, and gomisin A. The present work reviews newly-available literature concerning the cardioprotective potential of S. chinensis berries and their individual components. It places special emphasis on the cardioprotective properties of the selected lignans related to their antioxidant and anti-inflammatory characteristis.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Antioxidant activity of different extracts of dried and frozen fruits of Schisandra chinensis (Turcz.) Baill
    Terzieva, A. V.
    Vrancheva, R. Z.
    Delchev, N. D.
    BULGARIAN CHEMICAL COMMUNICATIONS, 2017, 49 : 78 - 82
  • [32] A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils.
    Yang, Ke
    Qiu, Jing
    Huang, Zecheng
    Yu, Ziwei
    Wang, Wenjun
    Hu, Huiling
    You, Yu
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 284
  • [33] Extraction and Separation of Active Ingredients in Schisandra chinensis (Turcz.) Baill and the Study of their Antifungal Effects
    Yi, Haijing
    Chen, Yan
    Liu, Jun
    Zhang, Jie
    Guo, Wei
    Xiao, Weilie
    Yao, Yuncong
    PLOS ONE, 2016, 11 (05):
  • [34] Optimization of culturing conditions for production of somatic embryos and lignins of Schisandra chinensis (Turcz.) Baill
    Sun, Dan
    Wang, Zhenxing
    Yu, Yunfei
    Li, Changyu
    Qin, Hongyan
    Xu, Peilei
    Zhao, Ying
    Liu, Yingxue
    Yang, Yiming
    Fan, Shutian
    Ai, Jun
    ACTA PHYSIOLOGIAE PLANTARUM, 2018, 40 (09)
  • [35] An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill
    Chen, Yong
    Tang, Jinbao
    Wang, Xiaoke
    Sun, Fengxiang
    Liang, Shujuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2012, 50 (03) : 844 - 848
  • [36] Simultaneous Determination of Three Active Ingredients in Schisandra chinensis (Turcz.) Baill by HPLC
    Cheng, Weiming
    Gao, Jie
    Zhong, Shan
    ASIAN JOURNAL OF CHEMISTRY, 2014, 26 (08) : 2434 - 2436
  • [37] Isolation, Characterization and Hypoglycemic Activity of an Acid Polysaccharide Isolated from Schisandra chinensis (Turcz.) Baill
    Gao, Xiaoxv
    Meng, Xianjun
    Li, Jihai
    Tong, Haibin
    LETTERS IN ORGANIC CHEMISTRY, 2009, 6 (05) : 428 - 433
  • [38] Identification of Quality Markers in Schisandra chinensis (Turcz.) Baill. Using UPLC-Q-Extractive Orbitrap/MS, Chemometric Analysis, and Network Pharmacology
    Wang, Yinpeng
    Li, Yumei
    Ding, Yan
    Du, Xinxin
    Zhu, Jingbo
    SEPARATIONS, 2024, 11 (03)
  • [39] Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies
    Agnieszka Szopa
    Radosław Ekiert
    Halina Ekiert
    Phytochemistry Reviews, 2017, 16 : 195 - 218
  • [40] Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies
    Szopa, Agnieszka
    Ekiert, Radoslaw
    Ekiert, Halina
    PHYTOCHEMISTRY REVIEWS, 2017, 16 (02) : 195 - 218